Catecholamines: Knowledge and understanding in the 1960s, now, and in the future

por Stanford, S. Clare, Heal, David J.
Publicado 2019

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

por Heal, David J, Smith, Sharon L
Publicado 2021

Contrasting changes in extracellular dopamine and glutamate along the rostrocaudal axis of the anterior cingulate cortex of the rat following an acute d-amphetamine or dopamine cha...

por Ash, Elizabeth S., Heal, David J., Clare Stanford, S.
Publicado 2014

The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulner...

por Pillidge, Katharine, Heal, David J, Stanford, S Clare
Publicado 2016

Amphetamine, past and present – a pharmacological and clinical perspective

por Heal, David J, Smith, Sharon L, Gosden, Jane, Nutt, David J
Publicado 2013

Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knockout’ mice

por Pillidge, Katharine, Porter, Ashley J., Vasili, Temis, Heal, David J., Stanford, S. Clare
Publicado 2014

Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement

por Palandri, Josephine, Smith, Sharon L, Heal, David J, Wonnacott, Sue, Bailey, Chris P
Publicado 2021

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine‐conditioned place preference and associated changes in AMPA rec...

por Wright, Victoria L., Georgiou, Polymnia, Bailey, Alexis, Heal, David J., Bailey, Christopher P., Wonnacott, Susan
Publicado 2018

The behavioural response of mice lacking NK(1) receptors to guanfacine resembles its clinical profile in treatment of ADHD

por Pillidge, Katharine, Porter, Ashley J, Dudley, Julia A, Tsai, Yuan-Chen, Heal, David J, Stanford, S Clare
Publicado 2014